Canaccord Genuity Reiterates Bullish Stance on Nu Skin (NUS)

Article Stock Quotes (2) Comments (0)

Canaccord Genuity reiterated their Buy rating and $66 price target on Nu Skin Enterprises (NYSE: NUS) saying "focus can now return to the fundamentals and the enormous success of product launches occurring this quarter in the Greater China and SE Asia regions."

The firm sees a powerful product cycle, coupled with a concerted effort to improve margins that should drive above-average EPS growth.

Canaccord is raising F2012 and F2013 EPS estimates to $3.03 and $3.45 from $2.95 and $3.40, respectively, to reflect the stronger-than-expected launches this quarter.

NOTE: Shares of NUS have been under pressure as they've been tied to David Einhorn's potential short on Herbalife Ltd. (NYSE: HLF) and speculation he would mention it at yesterday's Ira Sohn conference. Einhorn did not mention the stock.

For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.

Shares of Nu Skin Enterprises closed at $46.46 yesterday, with a 52 week range of $35.07-$62.02.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Bulls and Bears Do Battle in Aeropostale (ARO); Turnaround Intact?
• Janney Capital Boosts PT on Gap (GPS) Post Q1
• UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy

Create E-mail Alert Related Categories

Analyst Comments, Trader Talk

Related Entities

Greenlight Capital, David Einhorn

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?